Cargando…
The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
INTRODUCTION: Cognitive impairment is a common feature of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). However, there is a lack of population-based study of dementia risk in these disorders. In the present study, the risk of dementia in MS and NMOSD patients in Republi...
Autores principales: | Cho, Eun Bin, Jung, Se Young, Jung, Jin-Hyung, Yeo, Yohwan, Kim, Hee Jin, Han, Kyungdo, Shin, Dong Wook, Min, Ju-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309000/ https://www.ncbi.nlm.nih.gov/pubmed/37397465 http://dx.doi.org/10.3389/fnins.2023.1214652 |
Ejemplares similares
-
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020) -
Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
por: Hyun, Jae-Won, et al.
Publicado: (2020) -
Association of subcortical structural shapes with fatigue in neuromyelitis optica spectrum disorder
por: Seok, Jin Myoung, et al.
Publicado: (2022) -
Deep Learning-Based Method to Differentiate Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
por: Kim, Hyunjin, et al.
Publicado: (2020) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)